期刊文献+

微小剂量肝素在肝癌介入术后DIC预防性治疗中的应用 被引量:2

原文传递
导出
摘要 目的:通过对原发性肝癌患者在介入治疗后血浆中DIC分子标志物的检测,探讨微小剂量肝素预防DIC的作用。方法:27例患者依就诊顺序编入肝素组(14例)及对照组(13例)。测定肝动脉插管栓塞化疗术后血浆组织因子、组织因子途径抑制物、凝血酶、抗凝血酶Ⅲ和D-二聚体含量。结果:介入治疗后早期肝素组组织因子途径抑制物、抗凝血酶Ⅲ和D-二聚体含量均明显增高。结论:早期应用肝素可以降低血液的高凝状态。
出处 《中国误诊学杂志》 CAS 2010年第6期1305-1306,共2页 Chinese Journal of Misdiagnostics
  • 相关文献

参考文献5

二级参考文献39

  • 1熊立凡,王鸿利.D-二聚体与静脉血栓症诊断——循证实验诊断学举例[J].诊断学理论与实践,2005,4(1):75-79. 被引量:35
  • 2程慧敏.血浆尿激酶型血浆素原激活物作为肝细胞癌肿瘤标记物的临床探讨[J].国外医学:肿瘤学分册,1995,22:55-56.
  • 3Zhang Q, Larng Zy, Xue Q, et al. Invasion and metastasis of hepatocellular carcinoma in retation to urokinase-type plasmilogen activator, its receptor and inhibitor. J Cancer Res Clin Oncol , 2000126:641.
  • 4Ten Cate H, Timmerrnan JJ, Levi M. The pathophysiology of disseminated intravascular coagulation. Thromb Haemost, 1999, 82:713.
  • 5Fox SB, Turner GD, C, atter KC, et al, The increased expression of adhesion molecules ICAM-3, E-and P-selection on breast cancer en-dotheliurn. J Pathol , 1995,177:369.
  • 6Mammen EF. Coagulopathies of liver disease. Clin Lab Med, 1994, 14: 769-780.
  • 7Bick RL, Strauss JF, Frenkel EP. Thrombosis and hemorrhage in oncology patients. Hematol Oncol Clin North Am, 1996, 10: 875-907.
  • 8ten Cate H, Timmerman JJ, Levi M. The pathophysiology of disseminated intravascular coagulation. Thromb Haemost, 1999, 82: 713-717.
  • 9Mammen EF. Disseminated intravascular coagulation (DIC). Clin Lab Sci, 2000, 13: 239 -245.
  • 10Carey MJ, Rodgers GM. Disseminated intravascular coagulation: clinical and laboratory aspects. Am J Hematol, 1998, 59: 65-73.

共引文献43

同被引文献18

  • 1姜文清,胡豫,曹雁阁,陈力平,石珍.肝癌介入治疗前后弥漫性血管内凝血分子标志物的检测及临床意义[J].中西医结合肝病杂志,2007,17(6):366-368. 被引量:2
  • 2Vonderheide RH,Flaherty KT,Khalil M,et al.Clinical activity and immune modulation in cancer patients treated with CP-870,893,a novel CD40 agonist monoclonal antibody[J].J Clin Oncol,2007,25:876-883.
  • 3Eisenhauer EA,Therasse P,Boqaerts J,et al.New response evaluation criteria in solid tumours:revised RECIST guideline(version 1.1)[J].Eur J Cancer,2009,45:228-47.
  • 4Simonds NI,Khoury MJ,Schully SD,et al.Comparative effectiveness research in cancer genomics and precision medicine:current landscape and future prospects[J].J Natl Cancer Inst,2013,105:929-936.
  • 5Sudul T,Domagala-Kulawik J.Clinical manifestation and radiological features of small cell lung cancer(SCLC)[J].Wiad Lek,2012,65:97-101.
  • 6彭拥军,王超.原发性肝癌肝动脉栓塞介入治疗前后D二聚体变化的临床意义[J].现代消化及介入诊疗,2010,15:311-312.
  • 7Wang NY,Wang C,Li W,et al.Prognostic value of serum AFP,AFP-L3,and GP73 in monitoring short-term treatment response and recurrence of hepatocellular carcinoma after radiofrequency ablation[J].Aaian Pac J Cancer Prev,2014,15:1539-1544.
  • 8Msch M,Czabanka M,Dengler J,et al.D-dimer elevation and paresis predict thromboembolic events during bevacizumab therapy for recurrent malignant glioma[J].Anticancer Res,2013,33:2093-2098.
  • 9熊正平,黄芳,梁赵玉,黄斌,黄满平,李国文,古善智.奈达铂联合氟尿嘧啶栓塞治疗中晚期肝癌的临床观察[J].临床肿瘤学杂志,2011,16(11):1023-1025. 被引量:4
  • 10王晓蕊,黄彩云,韩素桂,张景华,李世龙,周秀艳.原发性肝癌患者血清中AFP-L3、GP73检测的评价[J].标记免疫分析与临床,2012,19(6):330-333. 被引量:11

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部